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Mild, calcium catalysed Beckmann
rearrangements†
H. J. Kiely-Collins,a I. Sechi,a P. E. Brennan *ab and M. G. McLaughlin *ac
A mild calcium catalysed Beckmann rearrangement has been
realised, which forgoes the more traditional harsh reactions con-
ditions associated with the transformation. The catalyst system is
shown to be tolerant towards a wide variety of functional groups
relevant to natural product synthesis and medicinal chemistry and
the synthetic utility of the reaction has also been investigated.
A preliminary mechanistic investigation was performed to under-
stand the nature of the incoming nucleophile and a possible reac-
tion pathway is described.
The Beckmann rearrangement of aldoximes and ketoximes to the
corresponding amides under acidic conditions is an inherently
elegant transformation, and has been used to great success in the
synthesis of natural products and pharmaceuticals alike.1
Although the reaction has clear utility in synthetic organic chem-
istry, the need for harsh reaction conditions limits its usefulness
to carefully chosen substrates.
In response to this problem, many groups have reported
modifications of the reaction that allows the transformation to
proceed under milder conditions. For example, Giacomelli
reported that cyanuric chloride aﬀorded the desired amides
in good yield,2 and Yamamoto and co-workers realized the
catalytic variant using an acid co-catalyst.3 Other catalytic variants
have been reported such as the use of TPAC,4 gold,5 chloral,6
mercury7 and iodine.8 Recently Mhaske and co-workers reported a
facile radical Beckmann rearrangement,9 while Yadav and collea-
gues harnessed visible light to power the reaction.10
Although all these methodologies provide the amides in
good yields, they suﬀer from intolerance to various functional
groups. Additionally, many of the reagents and catalysts used
could conceivably take part in side reactions, thus limiting their
uptake in industry (Scheme 1). During the course of a medicinal
chemistry project targeting epigenetic enzymes, we required a
mild and functional group tolerant method to synthesize a
library of amides11 for structure activity relationship studies.
Among the group 2 metals, calcium has been largely ignored
by the synthetic community, which is surprising as calcium is a
readily available and non-toxic metal.12 One major drawback
associated with using calcium as a reagent in synthesis is its
inherent lack of solubility in traditional organic solvents. How-
ever over the past decade, pioneering work by the groups of
Niggemann,13 Kobayashi,14 France,15 and others16 have shown
Scheme 1 Comparison with previously reported methodology.
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that calcium can be a highly powerful, yet mild catalyst for a
range of transformations.
Our group has a burgeoning interest in using alkaline earth
metals such as calcium as redox neutral catalysts to power
organic transformations, and we reasoned that through judicious
choice of catalyst system we could perform a mild Beckmann
rearrangement to aﬀord a wide variety of amides. We anticipated
that the Lewis acidic nature of the calcium catalyst would be
suﬃcient in generating the nitrillium ion which subsequently
provides the requisite amide.
With this in mind we conducted an initial feasibility study to
determine if the reaction could proceed (Table 1). Pleasingly,
10 mol% Ca(NTf2)2/nBu4NPF6 at room temperature provided
the amide in 10% isolated yield. We were initially concerned
that the reaction was proceeding stoichiometrically; however
upon heating the mixture at 40 1C, the product was obtained
in 49% yield. Increasing the temperature further to 80 1C
increased both the rate of reaction and isolated yield, aﬀording
the product in 93% yield in 2 hours. We next explored the
possibility of decreasing the catalyst loading, but we observed
a steady decrease in isolated yield with decreasing catalyst
loading; however under prolonged reaction times the yield
can be recovered. Additionally, the reaction was set-up without
either the calcium or ammonium salt, and as shown the
reaction did not proceed. Furthermore, we also attempted the
reaction in the presence of HNTf2, however only trace amounts
of product were obtained in all cases.
We next turned our attention to the choice of solvent for the
reaction (Table 2). As noted, one of the main drawbacks in using
calcium as a reagent is its inherent insolubility in many organic
solvents. This is partly circumvented through the use of the
NTf2/nBu4NPF6 system, but it was noted early in this study that
the reactions performed in 1,2-dichloroethane (DCE), upon
prolonged reactions times, became heterogeneous. To combat this,
several solvents were tested including dichloromethane (DCM),
chlorobenzene, n-methyl-2-pyrrolidone (NMP) and dimethylforma-
mide (DMF), however a reduction in isolated yield was observed in
each case. We therefore focused our attention on using solvent
mixtures employing DCE as the major constituent. After extensive
experimentation, a 4 : 1mixture of DCE :DME proved optimum and
this was used throughout.
With these optimised conditions in hand, we probed the
substrate scope of the reaction (Table 3). Substituted aryl
groups underwent the rearrangement to aﬀord the requisite
amides in good yield with both electron donating (2b, 2e) and
electron withdrawing groups (2c) being well tolerated. Similar
to other reports on the Beckmann rearrangement, electron
withdrawing groups resulted in a much slower reaction rate.
Free amines (2d) also underwent the rearrangement in good
yields. Heteroaryls containing basic nitrogen atoms such as
Table 1 Optimisation studies
Entry Ca source Additive Temp. (1C) Time (h) Yield (%)
1 Ca(NTf2)2 nBu4NPF6 r.t. 12 10
2 Ca(NTf2)2 nBu4NPF6 40 12 49
3 Ca(NTf2)2 nBu4NPF6 60 12 73
4 Ca(NTf2)2 nBu4NPF6 80 2 93
5 Ca(NTf2)2 nBu4NPF6 80 12 93
6 Ca(NTf2)2 None 80 12 0
7 None nBu4NPF6 80 12 0
8 None None 80 12 0
Table 2 Solvent optimisation
Entry Solvent Temp. (1C) Time (h) Yield (%)
1 1,2-DCE 80 2 93
2 DCM 40 12 31
3 DMF 80 12 0
4 NMP 80 6 81
5 DME 80 6 71
6 Et2O 40 6 12
7 THF 80 6 39
8 DCE :DME (1 : 1) 80 2 86
9 DCE :DME (4 : 1) 80 2 92
10 DCE :DME (10 : 1) 80 2 81
Table 3 Substrate scope
a Reaction performed with 30 mol% catalyst Ca(NTf2)2/nBu4NPF6. All
reactions were performed with anhydrous solvents however no precau-
tions were taken to exclude air.
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pyridine (2f), indole (2g) and benzimidazole (2h) also under-
went clean conversion to the product in excellent yields.
Additionally, aryl acetal (2i) was also tolerated well, as was
Boc-protected piperidine (2j) which underwent the reaction
cleanly to aﬀord the desired amide in good yields. This demon-
strates the utility of our catalyst system toward acid labile
functional groups. Our attention then turned to the cyclic,
symmetrical oximes as these can provide ready access to a wide
range of medicinally relevant scaﬀolds. Simple cycloalkyl com-
pounds underwent the rearrangement (2k, 2l), cleanly aﬀording
the requisite lactam in high yields. Tetrahydropyranyl oxime
also performed well, aﬀording the oxazepanone (2m) in excellent
yield. Finally we investigated changing the group at R2, with n-Pr
(2n) and benzyl (2o) also cleanly rearranging to the requisite
amides in good yield.
We next wanted to demonstrate the synthetic utility of
calcium catalyst in a complex molecular setting, and chose to
perform the rearrangement on the oxime of Prasterone (3) and
pregnenolone (5) acetate. Under the optimised conditions, the
rearrangement proceeded smoothly furnishing the products
in high yield (Scheme 2).
To ensure that our methodology could be applicable in the
arena of total synthesis, we chose the well established synthesis
of the macrolide antibiotic azithromycin from erythromycin,
employing our catalyst system to mediate the key ‘‘trapped’’
Beckmann rearrangement.17 We were intially concerned that
the number of hydroxyl groups on the oxime would interfere
with the Beckmann, however we reasoned as none of them were
benzylic or vinylic, the formation of the carbocation generated
would be less favourable than the competing rearrangement.
Subjecting erythromycin oxime (7) to the established condi-
tions aﬀorded the desired trapped intermediate (Scheme 3).
Azithromycin (9) was then produced via the established
reduction (8) and Eschweiler–Clarke methylation protocol.18
Finally we turned our attention onto whether the reaction
could be performed as a one pot procedure. After screening
several inorganic bases (NaOAc, Na2CO3, K2CO3) with little
success, we speculated that due to the high tolerance of the
calcium catalyst to nitrogen heterocycles, pyridine may be the
optimum choice. This proved to be the case, and the reaction
proceeded smoothly to aﬀord the amide in excellent yield.
As shown, further examples also proved successful (Table 4).
The initial mechanistic steps for the Beckmann rearrangements
have been argued over and subjected to prolonged investigation over
the past 50 years.19 It is generally accepted that after activation and
dehydration of the oxime, a reactive nitrillium ion is formed.
Consequently, the preformed water attacks this reactive inter-
mediate, which following tautomerization, aﬀords the requisite
amide. We wanted to investigate the nature of the incoming
nucleophile, and whether it was free water or a calcium-alkoxide
type species.We therefore attempted the reactionwith 1b, employing
4 Å molecular sieves to remove molecular water from the reaction,
and observed full conversion to the amide in 2 hours. Based on this
preliminary result, a plausible reaction mechanism is described
below (Fig. 1). The calcium catalyst activates the hydroxyl moiety of
the oxime which produces transient [HO Ca2+ PF6
]. This poten-
tially attacks the nitrillium to form intermediate 3a, and following
loss of the amide, the active calcium species is regenerated through
recomplexation with PF6.
In conclusion we have developed a mild, catalytic Beckmann
rearrangement employing a calcium(II) catalyst. Our system is
tolerant of a range of functionalities pertinent to natural
product synthesis and medicinal chemistry, as well as allowing
the use of acid labile moieties. The synthetic utility of the
reaction has been demonstrated, and we show that the reaction
is ammenable to one pot. We propose a plausible mechanism
based on preliminary investigations, with further detailed
studies underway.
Scheme 2 Beckmann rearrangement of prasterone and pregnenolone
acetate.
Scheme 3 Synthesis of azithromycin via trapped Beckmann.
Table 4 One-pot oxime formation-Beckmann rearrangement
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